| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment
|
Bacci, G.
|
|
|
18 |
12 |
p. 2037-2040
|
artikel
|
| 2 |
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study
|
Cazzaniga, M.E.
|
|
|
18 |
12 |
p. 1976-1980
|
artikel
|
| 3 |
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases
|
Fayette, J.
|
|
|
18 |
12 |
p. 2030-2036
|
artikel
|
| 4 |
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
|
Midgley, R.S.
|
|
|
18 |
12 |
p. 2025-2029
|
artikel
|
| 5 |
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
|
Bécouarn, Y.
|
|
|
18 |
12 |
p. 2000-2005
|
artikel
|
| 6 |
A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients
|
Jadu, F.
|
|
|
18 |
12 |
p. 2015-2019
|
artikel
|
| 7 |
author index
|
|
|
|
18 |
12 |
p. 2063-2075
|
artikel
|
| 8 |
Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training
|
Schneider, C.M.
|
|
|
18 |
12 |
p. 1957-1962
|
artikel
|
| 9 |
Family functioning and adolescents' emotional and behavioral problems: when a parent has cancer
|
Gazendam-Donofrio, S.M.
|
|
|
18 |
12 |
p. 1951-1956
|
artikel
|
| 10 |
Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation
|
Horacek, J.M.
|
|
|
18 |
12 |
p. 2041
|
artikel
|
| 11 |
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis
|
Gallagher, D.J.
|
|
|
18 |
12 |
p. 1995-1999
|
artikel
|
| 12 |
International consensus on treatment of early breast cancer: radiotherapy issues A response to ‘International expert consensus on radiotherapy of early breast cancer’
|
Goldhirsch, A.
|
|
|
18 |
12 |
p. 2044-2045
|
artikel
|
| 13 |
International expert consensus on radiotherapy of early breast cancer
|
Arriagada, R.
|
|
|
18 |
12 |
p. 2043-2044
|
artikel
|
| 14 |
In this issue
|
|
|
|
18 |
12 |
p. 1919
|
artikel
|
| 15 |
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
|
Kim, D.-W.
|
|
|
18 |
12 |
p. 2009-2014
|
artikel
|
| 16 |
Oncology: a forgotten territory in Africa
|
Pezzatini, M.
|
|
|
18 |
12 |
p. 2046-2047
|
artikel
|
| 17 |
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination
|
Catania, C.
|
|
|
18 |
12 |
p. 1969-1975
|
artikel
|
| 18 |
Parental cancer and its effects on adolescents and their families
|
Ohannessian, C.
|
|
|
18 |
12 |
p. 1921-1922
|
artikel
|
| 19 |
Pathology and clinical course of MALT lymphoma with plasmacytic differentiation
|
Wöhrer, S.
|
|
|
18 |
12 |
p. 2020-2024
|
artikel
|
| 20 |
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
|
Sapino, A.
|
|
|
18 |
12 |
p. 1963-1968
|
artikel
|
| 21 |
Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer
|
Försti, A.
|
|
|
18 |
12 |
p. 1990-1994
|
artikel
|
| 22 |
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer
|
Joly, F.
|
|
|
18 |
12 |
p. 1935-1942
|
artikel
|
| 23 |
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
|
Kaufmann, M.
|
|
|
18 |
12 |
p. 1927-1934
|
artikel
|
| 24 |
Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type
|
Pautier, P.
|
|
|
18 |
12 |
p. 1985-1989
|
artikel
|
| 25 |
Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer
|
Muñoz, A.
|
|
|
18 |
12 |
p. 2045-2046
|
artikel
|
| 26 |
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
|
Reichmann, U.
|
|
|
18 |
12 |
p. 1981-1984
|
artikel
|
| 27 |
subject index
|
|
|
|
18 |
12 |
p. 2049-2062
|
artikel
|
| 28 |
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
|
Bijelic, L.
|
|
|
18 |
12 |
p. 1943-1950
|
artikel
|
| 29 |
Systemic chemotherapy does not increase the risk of gastrointestinal perforation
|
Asmis, T.R.
|
|
|
18 |
12 |
p. 2006-2008
|
artikel
|
| 30 |
Table of Contents
|
|
|
|
18 |
12 |
p. i-ii
|
artikel
|
| 31 |
The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
|
Casali, P.G.
|
|
|
18 |
12 |
p. 1923-1925
|
artikel
|
| 32 |
Triple-negative breast cancer: MRI features in 29 patients
|
Chen, J.-H.
|
|
|
18 |
12 |
p. 2042-2043
|
artikel
|
Tijdschrift beschrijving